Despite this, many ESRD patients have erythropoietin-resistant anemia and/or anemia of inflammation and cannot tolerate additional blood loss during hemodialysis, which would further worsen their anemia, prognosis, and quality of life11–13. The gene discussed is EPO; the disease is anemia.